
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities
Thomas A. Wadden, Ariana M. Chao, Molly Moore, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 4, pp. 453-473
Open Access | Times Cited: 54
Thomas A. Wadden, Ariana M. Chao, Molly Moore, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 4, pp. 453-473
Open Access | Times Cited: 54
Showing 1-25 of 54 citing articles:
Medications for Obesity
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 40
Kimberly A. Gudzune, Robert F. Kushner
JAMA (2024) Vol. 332, Iss. 7, pp. 571-571
Closed Access | Times Cited: 40
DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 17
Yehuda Handelsman, John E. Anderson, George L. Bakris, et al.
Metabolism (2024) Vol. 159, pp. 155931-155931
Open Access | Times Cited: 17
Nutritional considerations with antiobesity medications
Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury, et al.
Obesity (2024) Vol. 32, Iss. 9, pp. 1613-1631
Open Access | Times Cited: 17
Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury, et al.
Obesity (2024) Vol. 32, Iss. 9, pp. 1613-1631
Open Access | Times Cited: 17
Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology
Thomas A. Wadden, Gregory K. Brown, Christina Egebjerg, et al.
JAMA Internal Medicine (2024)
Open Access | Times Cited: 17
Thomas A. Wadden, Gregory K. Brown, Christina Egebjerg, et al.
JAMA Internal Medicine (2024)
Open Access | Times Cited: 17
Approach to Obesity Treatment in Primary Care
Susan Z. Yanovski, Jack A. Yanovski
JAMA Internal Medicine (2024) Vol. 184, Iss. 7, pp. 818-818
Closed Access | Times Cited: 11
Susan Z. Yanovski, Jack A. Yanovski
JAMA Internal Medicine (2024) Vol. 184, Iss. 7, pp. 818-818
Closed Access | Times Cited: 11
Physical Activity and Excess Body Weight and Adiposity for Adults. American College of Sports Medicine Consensus Statement
John M. Jakicic, Caroline M. Apovian, Daheia J. Barr‐Anderson, et al.
Medicine & Science in Sports & Exercise (2024) Vol. 56, Iss. 10, pp. 2076-2091
Closed Access | Times Cited: 9
John M. Jakicic, Caroline M. Apovian, Daheia J. Barr‐Anderson, et al.
Medicine & Science in Sports & Exercise (2024) Vol. 56, Iss. 10, pp. 2076-2091
Closed Access | Times Cited: 9
The past, present, and future of behavioral obesity treatment
Ariana M. Chao, Molly Moore, Thomas A. Wadden
International Journal of Obesity (2024)
Closed Access | Times Cited: 8
Ariana M. Chao, Molly Moore, Thomas A. Wadden
International Journal of Obesity (2024)
Closed Access | Times Cited: 8
Lifestyle Interventions for Obesity in the Era of GLP-1 Receptor Agonists
Jamy D. Ard, Kristina H. Lewis, Justin B. Moore
JAMA (2024) Vol. 332, Iss. 1, pp. 16-16
Closed Access | Times Cited: 6
Jamy D. Ard, Kristina H. Lewis, Justin B. Moore
JAMA (2024) Vol. 332, Iss. 1, pp. 16-16
Closed Access | Times Cited: 6
Robert L. Dubin, Steven B. Heymsfield, Éric Ravussin, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 5
Normal-weight central obesity and cardiometabolic disorders among Aboriginal and Torres Strait Islander Australians
Kedir Y. Ahmed, Utpal K. Mondal, M. Mamun Huda, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Kedir Y. Ahmed, Utpal K. Mondal, M. Mamun Huda, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
One Size Does Not Fit All: Special Considerations for Behavioral Health Providers Treating Patients Using GLP-1RA Medications for Obesity
Noreen A. Reilly-Harrington, Susan Himes, Jennifer Lauretti-Robbins, et al.
Cognitive and Behavioral Practice (2025)
Closed Access
Noreen A. Reilly-Harrington, Susan Himes, Jennifer Lauretti-Robbins, et al.
Cognitive and Behavioral Practice (2025)
Closed Access
Medikamentöse Therapie der Adipositas bei Kindern und Jugendlichen
Julia Lischka, Gabriel Torbahn, Katharina Mörwald, et al.
Monatsschrift Kinderheilkunde (2025)
Open Access
Julia Lischka, Gabriel Torbahn, Katharina Mörwald, et al.
Monatsschrift Kinderheilkunde (2025)
Open Access
Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial
Jena Shaw Tronieri, Elham Ghanbari, Jonathan D Chevinsky, et al.
Nature Medicine (2025)
Open Access
Jena Shaw Tronieri, Elham Ghanbari, Jonathan D Chevinsky, et al.
Nature Medicine (2025)
Open Access
EFICÁCIA COMPARADA ENTRE SEMAGLUTIDA E TIRZEPATIDA PARA TRATAMENTO DE OBESIDADE: UMA REVISÃO DE LITERATURA
Júlia Moreno Turchetto, Gabriela Faria, Emilene Dias Fiuza Ferreira
Revista Foco (2025) Vol. 18, Iss. 3, pp. e8015-e8015
Open Access
Júlia Moreno Turchetto, Gabriela Faria, Emilene Dias Fiuza Ferreira
Revista Foco (2025) Vol. 18, Iss. 3, pp. e8015-e8015
Open Access
Exploring the perceptions of obesity, health habits, stigma, and eating behaviors in Brazil
Luiz F. Viola, Francine S. Mandel, Cynthia Melissa Valério, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Luiz F. Viola, Francine S. Mandel, Cynthia Melissa Valério, et al.
Diabetology & Metabolic Syndrome (2025) Vol. 17, Iss. 1
Open Access
Weight Loss with an AI-Powered Digital Platform for Lifestyle Intervention
Sarfraz Khokhar, John Holden, Catherine Toomer, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1810-1818
Closed Access | Times Cited: 4
Sarfraz Khokhar, John Holden, Catherine Toomer, et al.
Obesity Surgery (2024) Vol. 34, Iss. 5, pp. 1810-1818
Closed Access | Times Cited: 4
Exercise for Clients Taking an Anti-Obesity Medication
Renee J. Rogers
ACSMʼs Health & Fitness Journal (2024) Vol. 28, Iss. 3, pp. 21-26
Open Access | Times Cited: 4
Renee J. Rogers
ACSMʼs Health & Fitness Journal (2024) Vol. 28, Iss. 3, pp. 21-26
Open Access | Times Cited: 4
Assessing the state of obesity care: Quality, access, guidelines, and standards
Lee M. Kaplan, Caroline M. Apovian, Jamy D. Ard, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 4
Open Access | Times Cited: 4
Lee M. Kaplan, Caroline M. Apovian, Jamy D. Ard, et al.
Obesity Science & Practice (2024) Vol. 10, Iss. 4
Open Access | Times Cited: 4
Poor muscle quality: A hidden and detrimental health condition in obesity
Flávio Teixeira Vieira, Yaojun Cai, Marı́a Cristina González, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Closed Access
Flávio Teixeira Vieira, Yaojun Cai, Marı́a Cristina González, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Closed Access
A Randomized Controlled Trial of a Combined Physical Activity and Attitude Education Intervention on Weight Stigma and Health Outcomes
Hongyuan Huang, Xiao Xiao
Journal of School Health (2025)
Closed Access
Hongyuan Huang, Xiao Xiao
Journal of School Health (2025)
Closed Access
The role of antiobesity medications in alcohol use disorder treatment: a critical review
Marcello Maviglia, Norman J Cooeyate, Mauro Ceccanti
Journal of Psychology & Clinical Psychiatry (2025) Vol. 16, Iss. 1, pp. 14-22
Open Access
Marcello Maviglia, Norman J Cooeyate, Mauro Ceccanti
Journal of Psychology & Clinical Psychiatry (2025) Vol. 16, Iss. 1, pp. 14-22
Open Access
Impact of Anti‐obesity Medication Initiation and Duration on Weight Loss
M. Rami Bailony, P Espinoza, Harun Yüksel, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 2
Open Access
M. Rami Bailony, P Espinoza, Harun Yüksel, et al.
Obesity Science & Practice (2025) Vol. 11, Iss. 2
Open Access
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs
Sandra M. Christensen, Katie N. Robinson, Sara Thomas, et al.
Obesity Pillars (2024) Vol. 11, pp. 100121-100121
Open Access | Times Cited: 3
Sandra M. Christensen, Katie N. Robinson, Sara Thomas, et al.
Obesity Pillars (2024) Vol. 11, pp. 100121-100121
Open Access | Times Cited: 3
GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review
Candace Jarade, Tetiana Zolotarova, Areesha Moiz, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102789-102789
Open Access | Times Cited: 3
Candace Jarade, Tetiana Zolotarova, Areesha Moiz, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102789-102789
Open Access | Times Cited: 3
Contemporary Treatments for Obesity: Physical Activity in the Context of Antiobesity Medications
John M. Jakicic, Renee J. Rogers, Caroline M. Apovian
Translational Journal of the American College of Sports Medicine (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 2
John M. Jakicic, Renee J. Rogers, Caroline M. Apovian
Translational Journal of the American College of Sports Medicine (2024) Vol. 9, Iss. 2
Open Access | Times Cited: 2